drugset / Trial / NCT05593107

68Ga-N188 PET/CT Imaging in Malignancy

NCT05593107 ↗

Recruiting 203 enrolled Peking University First Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

The Nectin-4 protein belongs to the cell adhesion factors family and has a tissue-specific expression spectrum in normal human tissues. However, Nectin-4 is overexpressed in various malignancies, especially those of epithelial origins, such as uroepithelial carcinoma, making Nectin-4 a highly specific and significant imaging target for malignancies. \[68Ga\]N188, a novel molecular probe of PET imaging agent that targets Nectin-4, can be used in the diagnosis and research of a wide variety of Nectin-4 high-expression malignancies, including bladder cancer.

Timeline

Start
2022-08-12
Primary completion
2025-07-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-N188 Diagnostic / imaging agent 2.22 mbq/kg Intravenous
Subject 68Ga-N188 Diagnostic / imaging agent 2.96 mbq/kg Intravenous

Indications